Lawrence Walter
Indian Pharmaceutical Exporter ยท Diabetes & Endocrine Specialist ยท $2.0M Total Trade ยท DGFT Verified
Lawrence Walter is an Indian pharmaceutical exporter with a total trade value of $2.0M across 8 products in 4 therapeutic categories. Based on 5,666 verified export shipments from Indian Customs (DGFT) records, Lawrence Walter is the #1 Indian exporter in 1 product including Empagliflozin. Top exports include Empagliflozin ($848.8K), Fluticasone ($557.7K), Mesalamine ($297.2K).
Lawrence Walter โ Export Portfolio & Destination Treemap

Who is Lawrence Walter? โ Company Overview & Market Position
Lawrence Walter is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2010, the company is privately held and operates under the Corporate Identification Number (CIN) U45201MH2010PTC207702. The registered office is located at 1, La Petite Fleur, Gautam Buddha Marg, Opp. Orlem Church, Malad (W) Mumbai 400064, Maharashtra, India. The company has reported a total export value of $2.0 million USD over 5,666 shipments from 2022 to 2026, exporting eight products across four therapeutic categories. The workforce comprises approximately 50 employees. For more information, visit their website at www.lawrencewalter.com.